117 results
Page 3 of 6
8-K
EX-99.2
txg2r7jmwmsq
10 Dec 21
Regulation FD Disclosure
8:16am
424B5
y44g1 nl6mwp3a6
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
notxvfcfsq5n58sqyd
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.3
5xqx1ye 7wc7q3c9h
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-10.1
krzwlyl
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
8hju7
9 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
DEFA14A
xb7 o1q5rt5
26 Apr 21
Additional proxy soliciting materials
4:22pm
S-8
EX-23.2
8vv1jq9gjnys8n
1 Mar 21
Registration of securities for employees
12:00am
S-8
w6m9bnr51j op
1 Mar 21
Registration of securities for employees
12:00am
8-K
EX-1.1
xodyzit1
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
2j6bu206bh a2
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
mqbaiqnxujyxuy7
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
EX-4.5
3iitaj9t2ivan
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-23.1
ze3a5 bpfr3m9yuco
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
e40korluwf0gga8gj
14 Dec 20
Automatic shelf registration
4:02pm